Elevation of Plasma Soluble T Cell Costimulatory Molecules CTLA-4, CD28 and CD80 in Children with Allergic Asthma
Authors:
- C.K. WongCWC.K. Wong
- T.F. LeungTLT.F. Leung
- C.W.K. LamCLC.W.K. Lam
- 1 May 2005
- journal article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 137 (1) , 45-52
Abstract
Background: The surface expression of T cell costimulatory molecules CTLA-4 and CD28 and their counter-ligands, B7 molecules (CD80, CD86), is differentially induced for T cell activation and expansion in allergic asthma. However, the role of their soluble forms in plasma has not yet been elucidated. In this study, we investigated whether expression is altered and whether soluble costimulatory molecules are clinically relevant in asthmatic patients. Methods: Plasma concentrations of soluble CTLA-4 (sCTLA-4), CD28, CD80 and CD86 in 51 children with chronic allergic asthma with or without inhaled corticosteroid treatment, and 22 sex- and age-matched control subjects were measured by enzyme-linked immunosorbent assay. Plasma total IgE concentration was measured using a microparticle immunoassay. Results: Asthmatic patients had higher logarithmic plasma total IgE concentration (IgElog) than healthy subjects (p < 0.0001). In non-steroid-treated patients, plasma sCTLA-4, sCD28 and sCD80 but not sCD86 concentrations were significantly higher than those of control subjects (all p < 0.05). Plasma sCD80 and sCD86 but not sCTLA-4 and sCD28 concentrations correlated significantly with IgElog of all subjects (p < 0.05). There were also significant positive correlations between sCTLA-4 and sCD28 (p = 0.0007), and between sCD80 and sCD86 in all asthmatic patients (p = 0.001). Conclusions: Plasma sCTLA-4, sCD28 and sCD80 concentrations are elevated in allergic asthma. The increased expression of these soluble proteins may reflect the dysregulation of T cell activation, contributing to the immunopathogenesis of allergic asthma.Keywords
This publication has 43 references indexed in Scilit:
- Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patientsLeukemia, 2002
- The R576 IL-4 receptor α allele correlates with asthma severity☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cellsEuropean Journal of Immunology, 1999
- Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptorsImmunity, 1994
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994
- T cells and eosinophils in the pathogenesis of asthmaImmunology Today, 1992
- The two-signal model of lymphocyte activation twenty-one years laterImmunology Today, 1992
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989
- A 45‐kDa human T‐cell membrane glycoprotein functions in the regulation of cell proliferative responsesEuropean Journal of Biochemistry, 1984
- Predictive nomograms for forced expiratory volume, forced vital capacity, and peak expiratory flow rate, in Chinese adults and childrenRespiratory Medicine, 1983